Development of a PAT platform for the prediction of granule tableting properties.

Journal: International journal of pharmaceutics
Published Date:

Abstract

In this work, the feasibility of implementing a process analytical technology (PAT) platform consisting of Near Infrared Spectroscopy (NIR) and particle size distribution (PSD) analysis was evaluated for the prediction of granule downstream processability. A Design of Experiments-based calibration set was prepared using a fluid bed melt granulation process by varying the binder content, granulation time, and granulation temperature. The granule samples were characterized using PAT tools and a compaction simulator in the 100-500 kg load range. Comparing the systematic variability in NIR and PSD data, their complementarity was demonstrated by identifying joint and unique sources of variation. These particularities of the data explained some differences in the performance of individual models. Regarding the fusion of data sources, the input data structure for partial least squares (PLS) based models did not significantly impact the predictive performance, as the root mean squared error of prediction (RMSEP) values were similar. Comparing PLS and artificial neural network (ANN) models, it was observed that the ANNs systematically provided superior model performance. For example, the best tensile strength, ejection stress, and detachment stress prediction with ANN resulted in an RMSEP of 0.119, 0.256, and 0.293 as opposed to the 0.180, 0.395, and 0.430 RMSEPs of the PLS models, respectively. Finally, the robustness of the developed models was assessed.

Authors

  • Tibor Casian
    Department of Pharmaceutical Technology and Biopharmacy, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania. Electronic address: casian.tibor@umfcluj.ro.
  • Brigitta Nagy
    Department of Organic Chemistry and Technology, Budapest University of Technology and Economics, H-1111 Budapest, Műegyetem rakpart 3, Hungary.
  • Cristiana Lazurca
    Department of Pharmaceutical Technology and Biopharmacy, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
  • Victor Marcu
    Department of Pharmaceutical Technology and Biopharmacy, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
  • Erzsébet Orsolya Tőkés
    Gedeon Richter Romania 540306, Tîrgu Mureș, Romania.
  • Éva Katalin Kelemen
    Gedeon Richter Romania 540306, Tîrgu Mureș, Romania.
  • Katalin Zöldi
    Gedeon Richter Romania 540306, Tîrgu Mureș, Romania.
  • Radu Oprean
    Analytical Chemistry Department, "Iuliu Haţieganu" University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.
  • Zsombor Kristóf Nagy
    Department of Organic Chemistry and Technology, Faculty of Chemical Technology and Biotechnology, Budapest University of Technology and Economics, Műegyetem rkp. 3., H-1111 Budapest, Hungary.
  • Ioan Tomută
    Department of Pharmaceutical Technology and Biopharmacy, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
  • Béla Kovács
    Gedeon Richter Romania 540306, Tîrgu Mureș, Romania; Department of Biochemistry and Environmental Chemistry, Faculty of Pharmacy, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureș, 540139 Târgu Mureș, Romania.